Rx/reimbursement adult incontinence posted further positive value and volume sales growth in 2022, although the latter was slower compared to the previous year. This was due to the lower volume distribution of these products as part of government programmes, while the local population continued to age, with some turning to retail adult incontinence products instead.
The analyst's Rx/Reimbursement adult incontinence in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
The analyst's Rx/Reimbursement adult incontinence in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2027 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Rx/Reimbursement adult incontinence market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
RX/REIMBURSEMENT ADULT INCONTINENCE IN BRAZILKEY DATA FINDINGS
2022 DEVELOPMENTS
- Positive value and volume performance in 2022
- Lack of products is detrimental to older consumers and those with disabilities
- Supply chain disruptions indicate continuous market challenges
- Positive forecast related to investments in Farmácia Popular
- Growing demand for adult incontinence products driven by ageing population
- New prescription service for rx/reimbursement adult incontinence
- Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2017-2022
- Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2017-2022
- Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2022-2027
- Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2022-2027
EXECUTIVE SUMMARY
- Tissue and hygiene in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for tissue and hygiene?
- Table 5 Birth Rates 2017-2022
- Table 6 Infant Population 2017-2022
- Table 7 Female Population by Age 2017-2022
- Table 8 Total Population by Age 2017-2022
- Table 9 Households 2017-2022
- Table 10 Forecast Infant Population 2022-2027
- Table 11 Forecast Female Population by Age 2022-2027
- Table 12 Forecast Total Population by Age 2022-2027
- Table 13 Forecast Households 2022-2027
- Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2017-2022
- Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2017-2022
- Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2018-2022
- Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2019-2022
- Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2017-2022
- Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2017-2022
- Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2022
- Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2022-2027
- Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2022-2027
SOURCES
- Summary 1 Research Sources
